Author

R. L. Veres

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:non-human primate· 1 Assay:protein sequence· 1

Frequent Co-Authors

A. Akoopie· 1 shared A. R. Rappaport· 1 shared A. Shen· 1 shared A. Van Abbema· 1 shared C. D. Scallan· 1 shared G. R. Boucher· 1 shared G. Sivko· 1 shared J. A. Espinosa· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Akoopie

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A self-amplifying mRNA COVID-19 vaccine drives potent and broad immune responses at low doses that protects non-human primates against SARS-CoV-2

A. R. Rappaport, S.-J. Hong, C. D. Scallan, L. Gitlin, A. Akoopie, G. R. Boucher, M. Egorova, J. A. Espinosa, M. Fidanza, M. A. Kachura, A. Shen, G. Sivko, A. Van Abbema, R. L. Veres, K. Jooss

This paper develops a self-amplifying mRNA vaccine that induces strong immune responses in mice and non-human primates, offering protection against SARS-CoV-2 at low doses.

bioRxiv · Nov 8, 2021 · PreprintImmunology